Duff & Phelps Investment Management CO Amgen Inc Transaction History

Duff & Phelps Investment Management CO

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $1.3 Million - $1.58 Million	-4,946 Reduced 80.16%	1,224 $382,000
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $61,571 - $74,324	229 Added 3.85%	6,170 $1.75 Million
Q4 2023 Feb 05, 2024	BUY	$255.7 - $288.46 $8,949 - $10,096	35 Added 0.59%	5,941 $1.71 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $22,302 - $27,688	102 Added 1.76%	5,906 $1.59 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $77,214 - $87,083	-344 Reduced 5.6%	5,804 $1.31 Million
Q4 2021 Feb 07, 2022	BUY	$198.88 - $227.6 $5,170 - $5,917	26 Added 0.42%	6,148 $1.38 Million
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $31,415 - $36,807	-148 Reduced 2.36%	6,122 $1.3 Million
Q2 2021 Aug 09, 2021	SELL	$233.58 - $259.14 $131,972 - $146,414	-565 Reduced 8.27%	6,270 $1.53 Million
Q1 2021 May 10, 2021	SELL	$221.91 - $258.6 $22,191 - $25,860	-100 Reduced 1.44%	6,835 $1.7 Million
Q2 2020 Aug 06, 2020	BUY	$197.81 - $242.74 $23,737 - $29,128	120 Added 1.76%	6,935 $1.64 Million
Q3 2018 Oct 22, 2018	SELL	$185.29 - $208.89 $125,997 - $142,045	-680 Reduced 9.07%	6,815 $1.41 Million
Q2 2018 Aug 02, 2018	SELL	$166.05 - $186.51 $51,475 - $57,818	-310 Reduced 3.97%	7,495 $1.38 Million
Q1 2018 May 01, 2018	SELL	$169.43 - $198.0 $35,580 - $41,580	-210 Reduced 2.62%	7,805 $1.33 Million
Q4 2017 Jan 24, 2018	SELL	$168.79 - $188.59 $31,226 - $34,889	-185 Reduced 2.26%	8,015 $1.39 Million
Q3 2017 Oct 25, 2017	BUY	$167.29 - $191.0 $1.37 Million - $1.57 Million	8,200	8,200 $1.53 Million

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Duff & Phelps Investment Management CO, based on Form 13F filings with the SEC.

Stay updated on Duff & Phelps Investment Management CO with notifications on news.